Pregabalin

Herpes Zoster

CMH Kharian Medical CollegeSmall moleculePhase 4 / ApprovedActive

BB

69/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 56/ 100
Competitive Position: 89/ 100

Competitive context

6 Active assets in the Herpes Zoster cohort.

Asset / Sponsor	Phase	Rating
Capsaicin NeurogesX	Phase 3	BBB
ZOSTER VACCINE, LIVE, (OKA/MERCK) Louis Stokes VA Medical Center	Phase 4	BBB
Zoster Vaccine Recombinant, Adjuvanted GlaxoSmithKline	Phase 4	BBB
Foscarnet Cttq	Phase 4	BB
Gabapentine Dominik Irnich	Phase 4	BB

View all 26 →

Same molecule, other indications

Pregabalin is also rated in:

focal epilepsyDormant

A

Indicative ·

82 / 100

peripheral neuropathyDormant

A

Indicative ·

82 / 100

Depressive Disorder, MajorDormant

BBB

Indicative ·

76 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.